BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday, February 12, 2025. The firm expects ...
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...
BTIG raises Treace Medical stock to Buy, sets $16 target
Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...
BTIG Remains a Hold on Genco Shipping (GNK)
In a report released yesterday, Gregory Lewis from BTIG maintained a Hold rating on Genco Shipping (GNK – Research Report). The company’s ...
BTIG cuts IQVIA stock rating to neutral amid sector headwinds
BTIG analyst David Larsen adjusted the firm's stance on IQVIA Holdings (NYSE:IQV), moving from a Buy rating to Neutral. The $36.5 billion market cap company, currently trading near its 52-week low at ...
medtechdive7d
Doctors expect Boston Scientific to lead PFA race, survey finds
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Nasdaq1mon
BTIG Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...